Source Bioscience, an international provider of integrated laboratory services and products, has invested €585,000 in microbiology and sterility testing labs at its stability storage facility in Tramore, Co Waterford, Ireland. The investment expands the company’s current service offering at the site, adding a comprehensive suite of microbiology and sterility testing services with the aim of reducing turnaround times to allow more rapid feedback to customers and to minimize risk when storing samples.
 
Source BioScience has been providing outsourced stability storage services for more than 40 years and has served the Irish market since 2007. Recently rebranded as Source Stability Storage Solutions, the company offers a portfolio of stability storage options, delivering 24/7 outsourced controlled environment storage for stability trials at all World Climatic ICH conditions, as well as bespoke conditions. The investment supports the further expansion of this offering in the Irish and European markets.
 
“This investment brings major benefits to our customers,” said Brian Monaghan, Irish account manager, Source BioScience. “As a core offering, it means they can safely place products within our increasing number of ICH standard storage chambers, our fully trained and experienced microbiologists can access the chambers at required time points, test the product to establish acceptable limits and notify the client, with minimum disruption to samples. We are able to maintain a single quality agreement for a number of services which represents a major upside for our clients and offers great potential for reducing lead-times including the requirement for multiple audits, and minimizes risk to products.”
 
Russell Wheatcroft, commercial director, Source Bioscience, said, “We are thrilled to bring this investment and enhanced service to our valued current and future customers in Ireland. The funding is part of a two-stage process and we now look to expand our footprint in Ireland further by increasing the capacity of our Tramore facility by 40%. The Irish market is a key element to our expected growth in Europe and this investment will be critical in driving the Company through the next phase of its development.”